When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SRPT - Sarepta Versus The FDA And Other News: The Good Bad And Ugly Of Biopharma
Sarepta Therapeutics Inc.
Sarepta Therapeutics (SRPT) fell victim to the FDA's whims as the stock tumbled more than 3 percent following the issues raised by the FDA against its drug candidate Vyondys 53 (golodirsen). The drug was earlier rejected by the FDA last year. However, given what we can only call "popular protests," later the agency reversed its own decision in December and gave it a green signal. Now that the drug has been approved, the FDA decided to make its initial Complete Response Letter public, sending investors into a tizzy about its motives.